Welcome
By selecting the Yes, leave Opcaseportalmy.com option you understand that you are leaving the website and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Malaysia is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third-party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Malaysia. If you reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Acknowledgements
The clinical cases included in the Osteoporosis Case Binder were provided by the following experts:
Acknowledgements
Acknowledgements
Dato’ Dr. Joon-Kiong Lee DSPN, DJN
President, Malaysian Bone Health Optimization Network (MyBONe).
Past President, Fragility Fracture Network Malaysia (FFNM).
Deputy Medical Director and Consultant Orthopedic Surgeon
Beacon Hospital, Petaling Jaya, Malaysia.
Acknowledgements
Prof. Datuk Dr. Sabarul Afian Mokhtar
Senior Consultant Orthopaedic Surgeon
Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan
Malaysia (HCTM UKM)
Acknowledgements
Dato’ Dr Lim Boon Ping
Consultant Orthopaedic Surgeon, Subang Jaya Medical Cen
Acknowledgements
Dato' Dr Siva Kumar Ariaretnam
Consultant Orthopaedic Surgeon, Subang Jaya Medical Centre,
Malaysia
-
Important Safety Information:Osteoporosis Case BinderThis curated collection of patient case studies aims to provide healthcare practitioners in the area of bone health, with a comprehensive understanding of risk-based treatment approach in the long-term management of patients living with osteoporosis.The patient cases were contributed by bone health experts from respective clinical setting, incorporating evidence-based discussions, guidelines and clinical considerations in the individualised treatment sequencing plans of different real-world scenarios..Please review full product information before prescribingFor Healthcare Professionals Only.Please refer to full prescribing information prior to administrationFor information on Amgen products or to report an adverse event involving an Amgen product, please contact Medical Information at 1800 818 227 or medinfo.JAPAC@amgen.comSC-MAL-CP-00128-0425Endorsed By:
